Medical Research and Clinical Trials

Unveiling the Silent Architects of Heart Disease: How Gut Microbes are Reshaping Cardiovascular Medicine

• Medical Research and Clinical Trials

Unveiling the Silent Architects of Heart Disease: How Gut Microbes are Reshaping Cardiovascular Medicine

Pevita Pearce September 12, 2026

SEO Keywords: Cardiovascular disease, gut microbiome, coronary artery disease, metagenomic sequencing, inflammation, metabolism, precision medicine, Han-Na Kim,...

Read More Read more about Unveiling the Silent Architects of Heart Disease: How Gut Microbes are Reshaping Cardiovascular Medicine

Biohaven Pauses Pivotal Opakalim Trials Amidst FDA-Imposed Clinical Hold Due to Metabolite Safety Concerns

• Medical Research and Clinical Trials

Biohaven Pauses Pivotal Opakalim Trials Amidst FDA-Imposed Clinical Hold Due to Metabolite Safety Concerns

Evan Lee Salim September 12, 2026

New Haven, CT – [Insert Date] – Biohaven Pharmaceuticals has announced a significant pause in the pivotal...

Read More Read more about Biohaven Pauses Pivotal Opakalim Trials Amidst FDA-Imposed Clinical Hold Due to Metabolite Safety Concerns

A New Era for Breast Cancer Screening: WISDOM Study Champions Personalized, Risk-Based Approach

• Medical Research and Clinical Trials

A New Era for Breast Cancer Screening: WISDOM Study Champions Personalized, Risk-Based Approach

Pevita Pearce September 12, 2026

SAN ANTONIO, TX & SAN FRANCISCO, CA – December 12, 2023 – A landmark study, poised to...

Read More Read more about A New Era for Breast Cancer Screening: WISDOM Study Champions Personalized, Risk-Based Approach

Breakthrough in Menstrual Migraine Treatment: AbbVie’s Qulipta Shows Significant Efficacy in Late-Stage Trial

• Medical Research and Clinical Trials

Breakthrough in Menstrual Migraine Treatment: AbbVie’s Qulipta Shows Significant Efficacy in Late-Stage Trial

Raul Delapena Setiawan September 12, 2026

A significant stride has been made in addressing the debilitating impact of menstrual migraine, a condition that...

Read More Read more about Breakthrough in Menstrual Migraine Treatment: AbbVie’s Qulipta Shows Significant Efficacy in Late-Stage Trial

Unmasking a Master Regulator: Decades-Old Protein Reveals Surprising Role in Cancer Immunity, Offers New Therapeutic Hope

• Medical Research and Clinical Trials

Unmasking a Master Regulator: Decades-Old Protein Reveals Surprising Role in Cancer Immunity, Offers New Therapeutic Hope

Dwi Wanna September 12, 2026

Stanford, CA – April 24, 2024 – In a discovery poised to fundamentally reshape our understanding of...

Read More Read more about Unmasking a Master Regulator: Decades-Old Protein Reveals Surprising Role in Cancer Immunity, Offers New Therapeutic Hope

Beyond Pain Relief: Is Your Everyday Ibuprofen a Secret Weapon Against Cancer?

• Medical Research and Clinical Trials

Beyond Pain Relief: Is Your Everyday Ibuprofen a Secret Weapon Against Cancer?

Raul Delapena Setiawan September 11, 2026

Ibuprofen, a ubiquitous name in medicine cabinets worldwide, is a familiar ally against a myriad of ailments,...

Read More Read more about Beyond Pain Relief: Is Your Everyday Ibuprofen a Secret Weapon Against Cancer?

Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

• Medical Research and Clinical Trials

Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

Ammar Sabilarrohman September 11, 2026

NEW YORK, NY & CAMBRIDGE, MA – June 22, 2024 – In a significant breakthrough offering new...

Read More Read more about Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

TenNor Therapeutics Advances Promising PJI Treatment to Phase IIb Following Positive Phase IIa Data

• Medical Research and Clinical Trials

TenNor Therapeutics Advances Promising PJI Treatment to Phase IIb Following Positive Phase IIa Data

Nana Wu September 11, 2026

Shanghai, China – [Insert Date] – TenNor Therapeutics, a clinical-stage biopharmaceutical company, has announced a significant step...

Read More Read more about TenNor Therapeutics Advances Promising PJI Treatment to Phase IIb Following Positive Phase IIa Data

ERS 2026: Brensocatib cuts NCFB exacerbations in NTM history patients

• Medical Research and Clinical Trials

ERS 2026: Brensocatib cuts NCFB exacerbations in NTM history patients

Laily UPN September 11, 2026

To create a news article, I need actual journalistic content – facts, events, quotes, data, and context...

Read More Read more about ERS 2026: Brensocatib cuts NCFB exacerbations in NTM history patients

A New Horizon in Breast Cancer Prevention: Unveiling a Promising Alternative to Tamoxifen

• Medical Research and Clinical Trials

A New Horizon in Breast Cancer Prevention: Unveiling a Promising Alternative to Tamoxifen

Dwi Wanna September 11, 2026

Washington D.C. – A significant breakthrough in breast cancer prevention research offers a beacon of hope for...

Read More Read more about A New Horizon in Breast Cancer Prevention: Unveiling a Promising Alternative to Tamoxifen